HIGHLIGHTS
- who: Pt anticancer drugs and colleagues from the Guilin Medical University, China have published the Article: Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy, in the Journal: (JOURNAL)
- what: Due to the great success of Pt- and Ru-based metallodrugs in clinical usages or in clinic trials, in this review the authors aim to summarize and analyze the representative stimulantresponsive Pt- and Ru-based agents in lung cancer therapy.
- how: The results showed that the cytotoxicity was significantly stronger than that of cisplatin under blue light exposure.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.